RANDOMIZED CLINICAL EVALUATION OF EFFECTIVENESS COMPARISON BETWEEN DRUGS OPHTHALMOLOGICAL TOBRACORT® (TOBRAMYCIN + DEXAMETHASONE - LAB. UNIÃO QUÍMICA)AND TOBRADEX® (TOBRAMYCIN + DEXAMETHASONE - LAB. ALCON) IN REDUCING THE SIGNS AND SYMPTOMS OF ACUTE BACTERIAL CONJUNCTIVITIS

Date de début de l'étude : 1 février 2011

Inclusion Criteria: * Patients who agree with all study procedures and sign, by his own free will, IC; * Adult patients, regardless of gender, ethnicity or social status, with good mental health; * Patients who present at screening visit, a clinical picture of acute bacterial conjunctivitis diagnosed clinically. Exclusion Criteria: * Patients with clinical diagnosis of conjunctivitis due to any process other than bacterial infection, such as infections by fungi, protozoa, viruses, or allergic conjunctivitis; * Patients with a history or clinical diagnosis of other lesions that may affect the outcome, such as glaucoma, corneal ulcer or scars; * Patients with known hypersensitivity to any component of the study drug; * Concomitant use of ocular medication other than the study; * Patients who have made use of systemic anti-inflammatory hormone in the 30 days preceding inclusion; * Patients who have made use of systemic antibiotics in the 15 days preceding inclusion; * Pregnant or lactating women; * Being or having been treated for any type of conjunctivitis is less than 15 days, or have finished treatment at least 7 days